Ticker ALDX – Aldeyra The – sales, description, marketcap – Tickerday.com

ALDX

Aldeyra The

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 299.02M; Volume: 271.81K; AvgVol 3m: 1.05M; Beta: 2.00;

Cost estimate:

P/E: –; EPS: -1.75; EPS growth quarter/prev quarter: 49.40%;

EPS growth this year: -25.10%; EPS growth past 5 years: 2.20%;

EPS ttm: -1.75;

P/S: ; P/B: 04.09; P/Cashflow: 4.26; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -68.50%; ROE – return on equity: -100.90%; LT Debt/Equity: 0.26; Total Debt/Equity: 0.28;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 4.01%; Insider Transactions:202.18%;

Institutional Ownership: 42.90%; Institutional Transactions: -11.17%;

Data update: 07.10.2020.